CareLit Fachartikel
Pathogenesis and Diagnostics in Irritable Bowel Syndrome and the Potential Treatment with Probiotics
Claus Muss,Linda Mulder · Ernährung & Medizin · 2005 · Heft 2 · S. 73 bis 76
Dokument
311637
CareLit-ID
Jahr
2005
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Summary Irritable bowel syndrome (IBS) is a chronic relapsing condition which affects 10-20 % of all adults. It is a disease with unknown cause and no proven effective cure. Many factors have been discussed in the pathogenesis of IBS. Inflammatory cells are considered to be of a central role in the pathophysiology of IBS. Such cells may prime the gut and lead to an exaggerated inflammatory reaction entailing changes of motility in the gut. Abnormal gut flora and food intolerance is likely associated with such disturbances. Therefore the role of probiotic treatment in IBS has been examined in different studies wi…
Schlagworte
DIAGNOSTIK
ANTIDEPRESSIVA
INTERNATIONAL
IT
NAHRUNGSMITTEL
PATHOGENESE
PROGNOSE
SERUM
STUDIE
PROBIOTIKA
LOPERAMID
ENTZÜNDUNG
LACTOBACILLUS
Ernährung & Medizin
